GSK's clinical studies in Korea on the rise.

The foreign multinational drug corporations showed ever growing investment for the local clinical study projects in Korea, and GSK emerged as one of the most active companies to induce global clinical study programs into Korea.

GSK Korea said on Aug. 19 that as of May the company undertook the total 13 multinational clinical studies for 11 products in 9 different therapeutic groups including...